Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome
- 23 May 2003
- journal article
- other
- Published by Springer Nature in Leukemia
- Vol. 17 (6) , 1200-1202
- https://doi.org/10.1038/sj.leu.2402894
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Thalidomide and its analogues have distinct and opposing effects on TNF-αand TNFR2 during co-stimulation of both CD4+ and CD8+ T cellsClinical and Experimental Immunology, 2002
- Thalidomide for the treatment of patients with myelodysplastic syndromesLeukemia, 2002
- The clinical and biological effects of thalidomide in patients with myelodysplastic syndromesBritish Journal of Haematology, 2001
- Thalidomide in agnogenic and secondary myelofibrosisBritish Journal of Haematology, 2001
- Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromesBlood, 2001
- International Scoring System for Evaluating Prognosis in Myelodysplastic SyndromesBlood, 1997
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982